Product

NVX-Cov2373

Aliases

SARS-CoV-2 rS/Matrix-M Adjuvant

2 clinical trials

1 indication

Indication

Clinical trial

A Randomized, Observer-Blinded, Phase 3 Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults

Status: Completed, Estimated PCD: 2022-08-17

Clinical trial

A Multi-Part, Phase 3, Randomized, Observer Blinded Study to Evaluate the Safety and Immunogenicity of Omicron Subvariant and Bivalent SARS-CoV-2 rS Vaccines in Adults Previously Vaccinated With Other COVID-19 Vaccines

Status: Completed, Estimated PCD: 2022-07-17